Bayer shares fall 6% after court orders to pay $2,25 billion in damages
A Philadelphia court has ordered the German giant to compensate a Pennsylvania man who used the herbicide Roundup. The stock is near its 2010 lows
Glyphosate and cancer: Bayer sentenced to maxi compensation
The California court has recognized the "significant factor" of the herbicide Roundup in the illness of a couple with cancer and set a compensation of 2 billion - Stock market knockout.
Bayer, 12 cuts after merger with Monsanto
In total, the group employees are now 118 - Part of the freed up resources should be used to strengthen the innovation and competitiveness of the various divisions of the group.
Monsanto: judge wants to reduce fine and Bayer flies
The 289 million fine imposed on Monsanto for the accusation of causing cancer in a gardener through the use of glyphosate could be reduced - It is also possible that the trial will be re-tried
Bayer collapses on the stock market after the maxi-conviction against Monsanto
The German giant comes to lose more than 10% on the Frankfurt Stock Exchange after a US court sentenced Monsanto (a company with which Bayer recently completed the merger) to pay 289 million to a gardener who allegedly…
Twitter enters the S&P 500: from 7 June in place of Monsanto
The title celebrates the "promotion" on Wall Street with a shower of purchases - Netflix will replace Monsanto in the S&P 100
Bayer-Monsanto: the 7 billion wedding on June 63th
From June 7 Monsanto brand will disappear and its products will be sold only under their trademark - One of the biggest mergers in recent years completed - Bayer expects positive contribution to basic earnings per share…
Bayer sells assets to BASF to buy Monsanto
With this sale worth over 1,7 billion, the German giant satisfies the conditions set by the EU Antitrust to grant the go-ahead for the purchase of the US group - The agreement with BASF includes the transfer of 2.500 employees
Bayer: OK US Justice on Monsanto takeover, stock leaps
As happened a few weeks ago with the go-ahead from Brussels, also in this case the green light is "conditional" - The Bayer stock soars on the Dax 30, gaining more than 5%.
Bayer-Monsanto, from the EU yes (conditional) to the acquisition
Competition Commissioner Margrethe Vestager has given the green light to the operation as long as "the broad remedies proposed to eliminate the EU's doubts about overlaps in the seed, pesticide and digital agriculture markets are implemented" - This is why Bayer is about to give up…
Bayer: talks with BASF for sale of entire seeds sector
This was announced by the German group saying it is confident that, through this operation, it will meet the concerns of the European Commission, which has frozen the merger with the American Monsanto.
Glyphosate, EU green light for another five years
Germany's yes is decisive. Italy has voted against the proposal to renew the authorization of the herbicide which will remain banned in Italy for many types of use
Bayer sells assets to BASF for 5,9 billion
The German group sells the agrochemical activities to facilitate the union with Monsanto after the EU reliefs. The Union will decide by 8 January 2018
Bayer-Monsanto, EU says no to merger
The Bayer-Monsanto merger would create, warns the EU Antitrust, the world's largest integrated company of pesticides and seeds, seriously endangering competition on that market - The final decision by 8 January.
Bayer-Monsanto, Apple, Mps: three sparks for the market
The 66 billion merger between Bayer and Monsanto, the run of Apple which returns above 600 billion and the turnaround in Mps with the arrival of Morelli attract the spotlights of the market - Investors lighten their positions on stocks…
THE 5 TOP NEWS OF THE DAY
Sparkling day on the economic front: while the stock markets continue to flounder, Bayer places the coup and buys the US Monsanto for the record figure of 66 billion dollars - More news on pensions and another twist...
Monsanto goes to Bayer for 66 billion
After so many refusals, the American giant accepts the latest offer from the German giant, which comes to put on the plate 128 dollars per share - Now we have to overcome the launch of the Antitrust authorities, but for Bayer there is also the risk of a…
Stock exchanges await US and Monsanto stocks
Weak European markets in the middle of the day: although the price of oil is on the rise, expectation is for the afternoon with the data on American inventories. The announcement of the agreement on the mega-acquisition of Monsanto by Bayer with…
Bayer: sales in sight for Monsanto deal
The group is preparing the sale of the dermatology division. Bloomberg's indiscretion causes the stock to slide on the Stock Exchange
M&A, Bayer one step away from the wedding with Monsanto
The Germans raise their offer for Monsanto up to 135 dollars per share and breach the heart of the American agribusiness giant - The next few weeks will be decisive: if the final negotiations go through, the world leader in pesticides will be born…
Bayer ready to launch takeover bid on Monsanto
According to the German newspaper Handelsblatt, Bayer is expected to make a decision in the coming weeks as the discussions are at a decisive stage.
Monsanto: another no to the wedding with Bayer
The American agrochemical group once again rejects the offer of the German pharmaceutical giant: the board of directors judged the 64 billion dollar proposal "inadequate".
Bayer raises on Monsanto
The cash offer for the acquisition of the American group has been raised from 122 to 125 dollars per share - The Germans will pay Monsanto 1,5 billion dollars if the combination were to fall apart for antitrust reasons.
Bayer: Monsanto rejects the offer, but is open to negotiation
The Board of the American agrochemical group considers the proposal "incomplete and financially inadequate, but is open to continuing constructive discussions to understand whether"a transaction that is in the best interests of Monsanto shareholders can be achieved".
Bayer offers $62 billion in cash to take over Monsanto
The German chemical-pharmaceutical group has announced that it has presented the maxi-offer to take possession of the US agro-chemical company. Here are the details
Bayer confirms offer for Monsanto, stock down
According to estimates by the Reuters agency, the merger between the German pharmaceutical group and the leading US biotechnology company would give rise to a group with a turnover of approximately 60 billion euros.